Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
2.06
-0.10 (-4.63%)
At close: Sep 05, 2025, 3:59 PM
2.05
-0.49%
After-hours: Sep 05, 2025, 07:51 PM EDT
-4.63% (1D)
| Bid | 2.01 |
| Market Cap | 94.07M |
| Revenue (ttm) | 166K |
| Net Income (ttm) | -5.47M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -7.92 |
| Forward PE | -3.22 |
| Analyst | Buy |
| Ask | 2.2 |
| Volume | 210,690 |
| Avg. Volume (20D) | 123,854 |
| Open | 2.19 |
| Previous Close | 2.16 |
| Day's Range | 2.01 - 2.19 |
| 52-Week Range | 1.50 - 2.79 |
| Beta | 1.69 |
About ENTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+10.75%
Entera Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
5 months ago
+3.72%
Entera Bio shares are trading higher after entering a collaboration agreement with OPKO Health to advance a GLP-1/Glucagon candidate.
